Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Motor Activity × cytisine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Smoking Cessation 1 Motor Activity 1 Lung Neoplasms 1 Inflammation 1

Interventions

Exercise 10 Methods 2 Behavior Therapy 2 secukinumab 1 peficitinib 1 lime 1 cytisine 1 Waiting Lists 1 Telemedicine 1 Spirometry 1 Resistance Training 1 Nutrition Assessment 1 Memantine 1 High-Intensity Interval Training 1 Hematologic Tests 1 Health 1 Exergaming 1 Diet Therapy 1 Diet 1 Counseling 1 Clinical Trials as Topic 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03654105 2024-03-07

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡